NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Tuesday reported second-quarter earnings of $23.8 million.
On a per-share basis, the Newton, Massachusetts-based company said it had net loss of 20 cents.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.
The pharmaceutical company posted revenue of $42.8 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $36.1 million.
Karyopharm Therapeutics expects full-year revenue in the range of $145 million to $160 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KPTI at https://www.zacks.com/ap/KPTI
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
